Democrats say Trump increased investments in drugmakers that were given Medicare exemptions
Summary
A report from congressional Democrats says President Donald Trump's investments in drug companies grew a lot after he returned to the White House in 2024. Many of these companies benefited from a Republican law that protects some drugs from Medicare price negotiations.Key Facts
- President Trump's pharmaceutical stock holdings rose from about $1.7 million in 2024 to as much as $56.2 million by the end of 2025.
- Up to $39.1 million of his stock was in companies helped by a Republican law that exempts certain drugs from Medicare price talks.
- This law was part of a 2025 tax and spending bill passed with Republican support.
- Trump's portfolio made purchases totaling around $2.55 million in drug company stocks before he signed the law in July 2025.
- About $950,000 in stock was bought on July 1, 2025, when the Senate passed the bill.
- After the bill became law, up to $1 million in shares of AbbVie, a drug company, was bought in August 2025.
- The report came from the minority members of the Joint Economic Committee, which is a group of congressional lawmakers.
- The article notes that drug prices have declined recently, but the reasons behind this are complex.
Read the Full Article
This is a fact-based summary from The Actual News. Click below to read the complete story directly from the original source.
